Patent 7557106 was granted and assigned to Vertex Pharmaceuticals on July, 2009 by the United States Patent and Trademark Office.
The present invention provides a facile process for the preparation of tri- and tetra-substituted pyrimidines. The process is useful for preparing inhibitors of protein kinases, especially Aurora kinase. These inhibitors are useful for treating or lessening the severity of Aurora-mediated diseases or conditions.